Latest COVID-19 Vaccine Study in the UK Launches in London
On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.
By NIHR Wellcome King's Clinical Research Facility at 14 Apr 2021